This WG will focus its work in analysing the current literature on ureteral, urethral and prostatic stents from a multidisciplinary point of view.
The WG2 focuses its work in developing a computational setting to assess future stent designs, a world novelty.
The WG3 will be in charge of developing the Methodology and validation protocols of future urinary tract stents.
The WG4 will work on the search of new biomaterials-nanomaterials and coatings with improved behaviour at urinary tract level.
Following the idea of incorporating drugs onto the stent surface, several substances have already been used in DESs.
Coating of the stent surface is a developing field with significant potential for the reduction of stent-related complications.